Univet Pharmaceuticals Private Limited
About Univet Pharmaceuticals Private Limited
Data last updated:
Univet Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC065709. Its GSTIN is 09AAACU1070F1ZM (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.2 Lakh. It is led by directors Pankaj Kumar Nigam and Anil Frank.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 23 Ist Floor New Ashok Nagar, Delhi, India – 110096.
As per the financials filed for FY 2023, the company reported a revenue of ₹5.7 Cr. For the same year it recorded a net profit of ₹9.3 Lakh (net margin 1.6%) and EBITDA of ₹15.83 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Univet Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 23 Ist Floor New Ashok Nagar, Delhi, India – 110096
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Univet Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Univet Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Univet Pharmaceuticals Private Limited, buy the company report.
Financials of Univet Pharmaceuticals Private Limited
FY 2025 filings availableUnivet Pharmaceuticals Private Limited reported revenue of ₹5.7 Cr for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5.7 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Univet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Univet Pharmaceuticals Private Limited
Univet Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Kumar Nigam | Director | 22 Feb 1995 | 31 Years 8 Months | Current |
| Anil Frank | Director | 22 Feb 1995 | 31 Years 8 Months | Current |
Auditor
Univet Pharmaceuticals Private Limited is audited by D.K.A ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D.K.A ASSOCIATES | FY 2023 | 06094C |
Shareholding
The shareholding of Univet Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Univet Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Oct 2024 | 101029378 | Bank of India | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Univet Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North East, Delhi | Criminal case | Filed against the company by Icici Bank Ltd. | Disposed |
To see the full case history of Univet Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Univet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Univet Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACU1070F1ZM | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Univet Pharmaceuticals Private Limited, buy the company report.
Recent activity
Univet Pharmaceuticals Private Limited has 2 board changes on record since 1995: 2 appointments. The latest: Anil Frank was appointed as Director on 22 Feb 1995.
Frequently asked questions
Univet Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 February 1995 (31+ years old) and is registered under CIN U74899DL1995PTC065709.
Univet Pharmaceuticals has 2 current directors:
- Pankaj Kumar Nigam - Director
- Anil Frank - Director
The latest financial statements of Univet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Univet Pharmaceuticals is 09AAACU1070F1ZM, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Univet Pharmaceuticals is U74899DL1995PTC065709. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Univet Pharmaceuticals has 1 court case on record: 1 filed against it.
Univet Pharmaceuticals was incorporated on 22 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Frank was appointed as Director on 22 Feb 1995. Pankaj Kumar Nigam was appointed as Director on 22 Feb 1995.
The registered office of Univet Pharmaceuticals is at B – 23 Ist Floor New Ashok Nagar, Delhi, India – 110096.
Univet Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
